ArticleCancer science2025

Induction Camrelizumab and Modified TPF (Nab-Paclitaxel, Cisplatin, and S-1) in Locoregionally Advanced Nasopharyngeal Carcinoma.

Yi-Feng Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.